Genfit S.A. (GNFT)
NASDAQ: GNFT · IEX Real-Time Price · USD
3.970
-0.020 (-0.50%)
At close: Jul 2, 2024, 3:59 PM
3.980
+0.010 (0.25%)
After-hours: Jul 2, 2024, 4:00 PM EDT
Genfit Revenue
In the year 2023, Genfit had annual revenue of $42.42M with 50.09% growth.
Revenue (ttm)
$42.42M
Revenue Growth
+50.09%
P/S Ratio
4.66
Revenue / Employee
$266,778
Employees
159
Market Cap
197.54M USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 42.42M | 14.16M | 50.09% |
Dec 31, 2022 | 28.26M | -68.99M | -70.94% |
Dec 31, 2021 | 97.25M | 87.79M | 927.89% |
Dec 31, 2020 | 9.46M | -36.56M | -79.44% |
Dec 31, 2019 | 46.02M | 37.41M | 434.30% |
Dec 31, 2018 | 8.61M | 386.26K | 4.69% |
Dec 31, 2017 | 8.23M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Akebia Therapeutics | 187.23M |
Outset Medical | 125.08M |
The Joint | 119.12M |
ChromaDex | 83.17M |
2seventy bio | 71.20M |
Butterfly Network | 68.08M |
EDAP TMS | 65.80M |
GNFT News
- 15 days ago - GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH - GlobeNewsWire
- 22 days ago - GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis - GlobeNewsWire
- 22 days ago - US FDA approves Genfit and Ipsen's liver disease drug - Reuters
- 4 weeks ago - GENFIT to Present Latest ACLF Research at EASL Congress™ 2024 - GlobeNewsWire
- 5 weeks ago - GENFIT: May 22, 2024 Combined Shareholders Meeting Results - GlobeNewsWire
- 7 weeks ago - GENFIT Reports First Quarter 2024 Financial Information - GlobeNewsWire
- 2 months ago - GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023) - GlobeNewsWire
- 2 months ago - GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents - GlobeNewsWire